School of Medicine and Health Sciences Poster Presentations
Hypertriglyceridemia Among Transgender Patients on Hormone Therapy
Poster Number
255
Document Type
Poster
Status
Medical Student
Abstract Category
Health Sciences
Keywords
hypertriglyceridemia, transgender medicine, hormone replacement therapy
Publication Date
Spring 2018
Abstract
The field of transgender medicine is growing but research is needed in many areas such as the long term effects of hormone therapy. This study sought to determine 1) hypertriglyceridemia prevalence in patients both before and during hormone therapy; 2) whether or not hypertriglyceridemia is related to dose and/or formulation of estrogen or testosterone; 3) whether hypertriglyceridemia was related to other factors such as medications, BMI, blood pressure, and race/ethnicity. This retrospective study collected data from patients at the MFA endocrinology clinic and from Whitman Walker Clinic. Specifically, it included approximately 500 subjects, both trans men and trans women, on various types of estrogen or testosterone therapy. The data has been collected but has not been analyzed. Although no conclusions can be drawn at this time, the results from this study will hopefully inform clinicians and patients regarding potential adverse effects of hormone therapy.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Open Access
1
Hypertriglyceridemia Among Transgender Patients on Hormone Therapy
The field of transgender medicine is growing but research is needed in many areas such as the long term effects of hormone therapy. This study sought to determine 1) hypertriglyceridemia prevalence in patients both before and during hormone therapy; 2) whether or not hypertriglyceridemia is related to dose and/or formulation of estrogen or testosterone; 3) whether hypertriglyceridemia was related to other factors such as medications, BMI, blood pressure, and race/ethnicity. This retrospective study collected data from patients at the MFA endocrinology clinic and from Whitman Walker Clinic. Specifically, it included approximately 500 subjects, both trans men and trans women, on various types of estrogen or testosterone therapy. The data has been collected but has not been analyzed. Although no conclusions can be drawn at this time, the results from this study will hopefully inform clinicians and patients regarding potential adverse effects of hormone therapy.